1 company and 5 research reports found for "Amarantus BioScience"
- Amarantus BioScience
Amarantus BioScience is a US-based biotechnology company developing diagnostic and therapeutic produ...
No sector reports have been found.
Amarantus BioSciencePharmaceutical & healthcare | 09/11/2016
Edison Investment Research is terminating coverage on Amarantus Bioscience (AMBS). Please note you should no longer rely on any previous research or e...
Amarantus BioSciencePharmaceutical & healthcare | 27/07/2015
Amarantus has acquired several pre-commercial therapeutic assets in recent years, and intends to create value by furthering their development before o...
Amarantus BioSciencePharmaceutical & healthcare | 21/11/2014
Amarantus entered into an option agreement with Lonza to acquire its engineered skin substitute (ESS) platform for the treatment of severe burns. It p...
Amarantus BioSciencePharmaceutical & healthcare | 18/08/2014
Amarantus presented data of its blood-based diagnostic test for Alzheimer’s disease (AD), LymPro, at the Alzheimer’s Association Internati...